The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Management of Community-Acquired Pneumonia in Outpatient Clinic

지역사회획득 폐렴의 외래진료

  • Kim, Shin-Woo (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • 김신우 (경북대학교 의학전문대학원 내과학교실)
  • Published : 2011.11.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Song JH, Jung KS, Kang MW, et al. Treatment guidelines for community-acquired pneumonia in Korea: an evidence-based approach to appropriate antimicrobial therapy. Infect Chemother 2009;41:133-153. https://doi.org/10.3947/ic.2009.41.3.133
  2. Capelastegui A, España PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004;39:955-963. https://doi.org/10.1086/423960
  3. Martínez R, Reyes S, Lorenzo MJ, Menendez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009;30:172-178. https://doi.org/10.1055/s-0029-1202936
  4. Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International Cohort Study results. Arch Intern Med 2009; 169:1515-1524. https://doi.org/10.1001/archinternmed.2009.265
  5. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-S72.
  6. Smith MD, Sheppard CL, Hogan A, et al. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J Clin Microbiol 2009;47:1046-1049. https://doi.org/10.1128/JCM.01480-08
  7. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58: 377-382. https://doi.org/10.1136/thorax.58.5.377
  8. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T; CAPNETZ Study Group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006;260:93-101. https://doi.org/10.1111/j.1365-2796.2006.01657.x
  9. Arnold FW, Brock GN, Peyrani P, et al. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med 2010;104: 1736-1743. https://doi.org/10.1016/j.rmed.2010.05.022
  10. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1-iii55. https://doi.org/10.1136/thx.2009.121434
  11. Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 2007;86:103-111. https://doi.org/10.1097/MD.0b013e3180421c16
  12. Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:1086-1093. https://doi.org/10.1164/rccm.200603-350OC
  13. Marrie TJ, Poulin-Costello M, Beecroft MD, Herman-Gnjidic Z. Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir Med 2005;99:60-65. https://doi.org/10.1016/j.rmed.2004.05.010
  14. Robenshtok E, Shefet D, Gafter-Gvili A, Paul M, Vidal L, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2008:CD004418.
  15. Metlay JP, Atlas SJ, Borowsky LH, Singer DE. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med 1998;92:1137-1142. https://doi.org/10.1016/S0954-6111(98)90408-5